We have upgraded our recommendation from Reduce to Add after ASML reached our target price. We anticipate a positive development for the remainder of the year at both the top line and profitability, driven by structural improvements. This should place ASML in a good position to reach and even surpass the €13bn target for FY20 as well as its medium-term target.
15 Jul 2020
Q2 20: situation to normalise, FY20 to be a growth year indeed
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q2 20: situation to normalise, FY20 to be a growth year indeed
ASML Holding NV (ASML:WBO) | 0 0 1.0% | Mkt Cap: 67,287m
- Published:
15 Jul 2020 -
Author:
Hugo Paternoster -
Pages:
3
We have upgraded our recommendation from Reduce to Add after ASML reached our target price. We anticipate a positive development for the remainder of the year at both the top line and profitability, driven by structural improvements. This should place ASML in a good position to reach and even surpass the €13bn target for FY20 as well as its medium-term target.